These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 15047529)
21. Studies on the metabolism and disposition of the new retinoid 4-[(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthyl)carbamoyl] benzoic acid. 4th communication: absorption, metabolism, excretion and plasma protein binding in various animals and man. Mizojiri K; Okabe H; Sugeno K; Misaki A; Ito M; Kominami G; Esumi Y; Takaichi M; Harada T; Seki H; Inaba A Arzneimittelforschung; 1997 Mar; 47(3):259-69. PubMed ID: 9105544 [TBL] [Abstract][Full Text] [Related]
22. Caspofungin acetate: an antifungal agent. Hoang A Am J Health Syst Pharm; 2001 Jul; 58(13):1206-14; quiz 1215-7. PubMed ID: 11449878 [TBL] [Abstract][Full Text] [Related]
23. Antifungal efficacy of caspofungin (MK-0991) in experimental pulmonary aspergillosis in persistently neutropenic rabbits: pharmacokinetics, drug disposition, and relationship to galactomannan antigenemia. Petraitiene R; Petraitis V; Groll AH; Sein T; Schaufele RL; Francesconi A; Bacher J; Avila NA; Walsh TJ Antimicrob Agents Chemother; 2002 Jan; 46(1):12-23. PubMed ID: 11751105 [TBL] [Abstract][Full Text] [Related]
24. Compartmental pharmacokinetics and tissue distribution of the antifungal echinocandin lipopeptide micafungin (FK463) in rabbits. Groll AH; Mickiene D; Petraitis V; Petraitiene R; Ibrahim KH; Piscitelli SC; Bekersky I; Walsh TJ Antimicrob Agents Chemother; 2001 Dec; 45(12):3322-7. PubMed ID: 11709303 [TBL] [Abstract][Full Text] [Related]
25. Caspofungin: a review of its use in oesophageal candidiasis, invasive candidiasis and invasive aspergillosis. Keating G; Figgitt D Drugs; 2003; 63(20):2235-63. PubMed ID: 14498760 [TBL] [Abstract][Full Text] [Related]
26. Pharmacokinetics and metabolism in rats, dogs, and monkeys of the cathepsin k inhibitor odanacatib: demethylation of a methylsulfonyl moiety as a major metabolic pathway. Kassahun K; Black WC; Nicoll-Griffith D; McIntosh I; Chauret N; Day S; Rosenberg E; Koeplinger K Drug Metab Dispos; 2011 Jun; 39(6):1079-87. PubMed ID: 21422190 [TBL] [Abstract][Full Text] [Related]
27. Pharmacokinetics of L-671,329 in rhesus monkeys and DBA/2 mice. Sundelof JG; Hajdu R; Cleare WJ; Onishi J; Kropp H Antimicrob Agents Chemother; 1992 Mar; 36(3):607-10. PubMed ID: 1622170 [TBL] [Abstract][Full Text] [Related]
29. Disposition of irbesartan, an angiotensin II AT1-receptor antagonist, in mice, rats, rabbits, and macaques. Davi H; Tronquet C; Miscoria G; Perrier L; DuPont P; Caix J; Simiand J; Berger Y Drug Metab Dispos; 2000 Jan; 28(1):79-88. PubMed ID: 10611144 [TBL] [Abstract][Full Text] [Related]
30. Assessing the antifungal activity and toxicity profile of amphotericin B lipid complex (ABLC; Abelcet) in combination with caspofungin in experimental systemic aspergillosis. Sivak O; Bartlett K; Risovic V; Choo E; Marra F; Batty DS; Wasan KM J Pharm Sci; 2004 Jun; 93(6):1382-9. PubMed ID: 15124198 [TBL] [Abstract][Full Text] [Related]
31. Disposition and metabolism of rifapentine, a rifamycin antibiotic, in mice, rats, and monkeys. Emary WB; Toren PC; Mathews B; Huh K Drug Metab Dispos; 1998 Aug; 26(8):725-31. PubMed ID: 9698285 [TBL] [Abstract][Full Text] [Related]
32. Metabolism and disposition of [14C]BMS-690514 after oral administration to rats, rabbits, and dogs. Hong H; Su H; Sun H; Allentoff A; Ekhato IV; Chando T; Caceres-Cortes J; Roongta V; Iyer RA; Humphreys WG; Christopher LJ Drug Metab Dispos; 2010 Jul; 38(7):1189-201. PubMed ID: 20363952 [TBL] [Abstract][Full Text] [Related]
33. Pharmacokinetics and disposition of the novel dopamine agonist Z-7760 in rat after intravenous and oral administration. Bollard M; Caldwell J; Taylor GW; Strolin-Benedetti M; Semeraro C Xenobiotica; 2000 Oct; 30(10):983-91. PubMed ID: 11315106 [TBL] [Abstract][Full Text] [Related]
34. Species differences in the disposition and metabolism of sulfinpyrazone. Dieterle W; Faigle JW Xenobiotica; 1981 Aug; 11(8):559-68. PubMed ID: 7303725 [TBL] [Abstract][Full Text] [Related]
35. Pharmacokinetics and disposition of DY-9760e, a novel calmodulin antagonist, in rats and monkeys. Tachibana S; Fujimaki Y; Tachibana M; Tanaka M; Kurata T; Okazaki O; Sudo K Arzneimittelforschung; 2005; 55(3):135-44. PubMed ID: 15819385 [TBL] [Abstract][Full Text] [Related]
36. Cilofungin (LY121019) shows nonlinear plasma pharmacokinetics and tissue penetration in rabbits. Lee JW; Kelly P; Lecciones J; Coleman D; Gordee R; Pizzo PA; Walsh TJ Antimicrob Agents Chemother; 1990 Nov; 34(11):2240-5. PubMed ID: 2073114 [TBL] [Abstract][Full Text] [Related]
37. Species differences in the biotransformation of an alpha 4 beta 2 nicotinic acetylcholine receptor partial agonist: the effects of distinct glucuronide metabolites on overall compound disposition. Shaffer CL; Gunduz M; Ryder TF; O'Connell TN Drug Metab Dispos; 2010 Feb; 38(2):292-301. PubMed ID: 19910512 [TBL] [Abstract][Full Text] [Related]
38. Ciclesonide disposition and metabolism: pharmacokinetics, metabolism, and excretion in the mouse, rat, rabbit, and dog. Guo Z; Gu Z; Howell SR; Chen K; Rohatagi S; Cai L; Wu J; Stuhler J Am J Ther; 2006; 13(6):490-501. PubMed ID: 17122529 [TBL] [Abstract][Full Text] [Related]
39. Pharmacodynamics of caspofungin in a murine model of systemic candidiasis: importance of persistence of caspofungin in tissues to understanding drug activity. Louie A; Deziel M; Liu W; Drusano MF; Gumbo T; Drusano GL Antimicrob Agents Chemother; 2005 Dec; 49(12):5058-68. PubMed ID: 16304173 [TBL] [Abstract][Full Text] [Related]
40. Metabolic fate of the new angiotensin-converting enzyme inhibitor imidapril in animals. 6th communication: interspecies comparison of pharmacokinetics and excretion of imidapril metabolites in rats, dogs, and monkeys. Yamada Y; Endo M; Kohno M; Otsuka M; Takaiti O Arzneimittelforschung; 1992 Apr; 42(4):499-506. PubMed ID: 1642673 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]